Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Guillaume, Bouguéon"'
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 5, Iss 1, Pp 1760-4 (2020)
In the context of batch production of cytotoxic drugs in hospital pharmacies with the need of sterility testing, the objective was to validate the use of Rapid Microbiological Method (RMM), and to develop adequate neutralization method in case of inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c3cd2ae64993e4eacb0f893050c937
https://doaj.org/article/8499683dec67499582d9f5beb2afdf2e
https://doaj.org/article/8499683dec67499582d9f5beb2afdf2e
Autor:
Audrey Jourand, Guillaume Bouguéon, Sylvie Crauste-Manciet, Aude Berroneau, Thomas Deljehier, Jeanne Heloury
Publikováno v:
Pharmaceutical Technology in Hospital Pharmacy, Vol 4, Iss 1, Pp 15-28 (2019)
Two automation methods for aseptic preparation in hospital pharmacy, robot and peristaltic pump, were compared to manual process both for risk analysis using Failure Modes Effects and Criticality Analysis (FMECA) method and for productivity using tim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5adbba4d34923a0962f3184e67615ba5
https://doi.org/10.1515/pthp-2019-0001
https://doi.org/10.1515/pthp-2019-0001
Autor:
R. Legeron, Sybille De-Germay, Guillaume Bouguéon, Sylvie Crauste-Manciet, Jean-Marc Bernadou, Sarah Djabarouti, Aude Berroneau, F. Xuereb
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 78(9)
Purpose To investigate the long-term chemical and physical stability of 5-mg/mL acyclovir solution in polypropylene bags stored at 5°C ± 3°C for 2 months in order to determine the feasibility of batch production by a centralized intravenous additi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::741e8689f0d10a5232f8754bc02086a2
https://pubmed.ncbi.nlm.nih.gov/33630992
https://pubmed.ncbi.nlm.nih.gov/33630992
Autor:
Sylvie Crauste-Manciet, Valérie Moreno, Guillaume Bouguéon, Thomas Deljehier, Jeanne Heloury, Aude Berroneau
Publikováno v:
Journal of Oncology Pharmacy Practice. 25:1873-1890
The aim of this study was to develop a specific simulation program for the validation of a cytotoxic compounding robot, KIRO® Oncology, for the preparation of sterile monoclonal antibodies and anti-infectious drugs. The impact of excipient formulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a5194afbf975b858386263822dbb574
https://doi.org/10.1177/1078155218823911
https://doi.org/10.1177/1078155218823911
Autor:
Guillaume Bouguéon, Bérangère Dessane, Tina Kauss, Sylvie Crauste-Manciet, Philippe Barthélémy
Publikováno v:
Drug Discovery Today
Drug Discovery Today, Elsevier, 2019, 24, pp.163-178. ⟨10.1016/j.drudis.2018.10.013⟩
Drug Discovery Today, Elsevier, 2019, 24, pp.163-178. ⟨10.1016/j.drudis.2018.10.013⟩
Recent developments in bioprinting have enabled an optimized formulation of bioinks by incorporating pharmaceuticals into cell-containing gel matrices. The proof-of-printability of a variety of forms has been provided, such as particles and fibers in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14c03a4fc6aa3b9a8ac29caf2288dcb7
https://doi.org/10.1016/j.drudis.2018.10.013
https://doi.org/10.1016/j.drudis.2018.10.013
Autor:
Guillaume Bouguéon, Frédéric Lagarce, Guillaume Bastiat, Ludovic Martin, Sandy Vrignaud, Hélène Pailhoriès
Publikováno v:
International Journal of Pharmaceutics
International Journal of Pharmaceutics, Elsevier, 2016, 509 (1-2), pp.279-284. ⟨10.1016/j.ijpharm.2016.05.064⟩
International Journal of Pharmaceutics, Elsevier, 2016, 509 (1-2), pp.279-284. ⟨10.1016/j.ijpharm.2016.05.064⟩
International audience; Medicines for the treatment of rare diseases frequently do not attract the interest of the pharmaceutical industry, and hospital pharmacists are thus often requested by physicians to prepare personalized medicines. Tuberous Sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e9afda44601eff3e6164fcf98d2750f
https://hal.archives-ouvertes.fr/hal-01392471
https://hal.archives-ouvertes.fr/hal-01392471
Publikováno v:
Journées Dermatologiques de Paris
Journées Dermatologiques de Paris, 2015, Paris, France. pp.S668-S669, ⟨10.1016/j.annder.2015.10.515⟩
Journées Dermatologiques de Paris, 2015, Paris, France. pp.S668-S669, ⟨10.1016/j.annder.2015.10.515⟩
International audience; IntroductionParmi les différentes affections dermatologiques associées à la sclérose tubéreuse de Bourneville (STB), les angiofibromes faciaux sont les plus défigurants. Présents chez 85% des patients, leurs répercussi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c52f31261d80bf88a71023a9ce26d797
https://hal.archives-ouvertes.fr/hal-01393858
https://hal.archives-ouvertes.fr/hal-01393858
Autor:
Guillaume Bouguéon, X. Grimaux, J. Delaunay, S. Topin, D. Farges, Frédéric Lagarce, Sandy Vrignaud, L. Martin
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 143:S169
Introduction La sclerose tubereuse de Bourneville (STB) est caracterisee par le developpement d’hamartomes multiples dont les angiofibromes (AF). Cette pathologie induite par l’activation de la voie mTor beneficie depuis peu de l’introduction d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28f82eb6c81bb7460183629c61385650
https://doi.org/10.1016/j.annder.2016.09.192
https://doi.org/10.1016/j.annder.2016.09.192
Autor:
Deljehier, Thomas, Bouguéon, Guillaume, Heloury, Jeanne, Moreno, Valérie, Berroneau, Aude, Crauste-Manciet, Sylvie
Publikováno v:
Journal of Oncology Pharmacy Practice; Dec2019, Vol. 25 Issue 8, p1873-1890, 18p, 2 Color Photographs, 1 Diagram, 13 Charts, 2 Graphs